Cardiovascular mortality
Continuous positive airway pressure (CPAP) plus best supportive care showed no clear difference in cardiovascular mortality ‐ after 24 months Number of participants:… compared with best supportive care (low certainty).
1 finding from 1 review
RR 1.17 [0.68, 2.02]
Studies not reported
Low
Serious adverse events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of sleep
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
AHI
1 finding from 1 review
no estimate extracted
Studies not reported
Low
All‐cause mortality ‐ after 24 months Number of participants: 287(2 RCTs)
It is very uncertain whether continuous positive airway pressure (CPAP) plus best supportive care changes all‐cause mortality ‐ after 24 months Number of participants: 287(2… compared with best supportive care (very low certainty).
1 finding from 1 review
RR 1.14 [0.83, 1.56]
Studies not reported
Very low
Time to life‐saving cardiovascular intervention
Continuous positive airway pressure (CPAP) plus best supportive care may leads to lower time to life‐saving cardiovascular intervention ( compared with best supportive care (low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Hospital mortality · patients with cardiogenic pulmonary oedema
NPPV may leads to lower HOSPITAL MORTALITY compared with SMC (low certainty).
1 finding from 1 review
ETI RATE · patients with cardiogenic pulmonary oedema
NPPV probably leads to lower ETI RATE compared with SMC (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with cardiogenic pulmonary oedema
NPPV showed no clear difference in ACUTE MI INCIDENCE compared with SMC (moderate certainty).
1 finding from 1 review
Length of hospital stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Duration of ICU stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Intolerance to allocated treatment · patients with cardiogenic pulmonary oedema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Pulmonary complications (0 to 30 days) · Patients with lung cancer
NIPPV showed no clear difference in pulmonary complications compared with no NIPPV (low certainty).
1 finding from 1 review
Rate of intubation · Patients with lung cancer
NIPPV showed no clear difference in rate of intubation compared with no NIPPV (moderate certainty).
1 finding from 1 review
All‐cause mortality · Patients with lung cancer
NIPPV showed no clear difference in mortality compared with no NIPPV (moderate certainty).
1 finding from 1 review
Length of critical care stay (hours) · Patients with lung cancer
1 finding from 1 review
Length of hospital stay · Patients with lung cancer
1 finding from 1 review
Intervention not reported
Mortality · children with acute asthma
1 finding from 1 review